Literature DB >> 19087877

Expression of interleukin-1 receptor antagonist in human cornea.

Martin Heur, Shyam S Chaurasia, Steven E Wilson.   

Abstract

The purpose of this study was to confirm the expression of interleukin-1 receptor antagonist (IL-1 Ra) in the human cornea. Four samples of human ex vivo corneal epithelium were obtained from patients undergoing photorefractive keratectomy. RT-PCR was performed using mRNA isolated from the corneal epithelium and oligo-dT primers. PCR was performed on the cDNA products using primers specific for human IL-1 Ra. The PCR products were subcloned and sequenced. Human cornea sections were prepared from eyes enucleated for choroidal melanoma. Immunocytochemistry was performed using goat anti-mouse polyclonal IL-1 Ra IgG and NL-577 conjugated donkey anti-goat IgG. IL-1 Ra mRNA was expressed in all ex vivo corneal epithelium samples as confirmed by sequencing of the PCR products. Immunofluorescence studies revealed strongest expression of IL-1 Ra in the superficial apical layer of corneal epithelium. Expression of IL-1 Ra may represent an endogenous mechanism of down-regulating the effects of epithelial- and tear-derived IL-1alpha and IL-1beta on the intact epithelium in the unwounded cornea and stromal cells after injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19087877      PMCID: PMC2691719          DOI: 10.1016/j.exer.2008.11.019

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.

Authors:  A Solomon; D Dursun; Z Liu; Y Xie; A Macri; S C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

Review 3.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

4.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

Authors:  J K Tarlow; A I Blakemore; A Lennard; R Solari; H N Hughes; A Steinkasserer; G W Duff
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

5.  A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes.

Authors:  M J Nicklin; A Weith; G W Duff
Journal:  Genomics       Date:  1994-01-15       Impact factor: 5.736

6.  Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.

Authors:  W Michael Stapleton; Shyam S Chaurasia; Fabricio W Medeiros; Rajiv R Mohan; Sunilima Sinha; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-02-13       Impact factor: 3.467

7.  Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.

Authors:  Partha S Biswas; Kaustuv Banerjee; Bumseok Kim; Barry T Rouse
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 8.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

9.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.

Authors:  F E Clay; M J Cork; J K Tarlow; A I Blakemore; C I Harrington; F Lewis; G W Duff
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

10.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.

Authors:  J K Tarlow; F E Clay; M J Cork; A I Blakemore; A J McDonagh; A G Messenger; G W Duff
Journal:  J Invest Dermatol       Date:  1994-09       Impact factor: 8.551

View more
  5 in total

Review 1.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

Review 2.  Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation.

Authors:  Bakiah Shaharuddin; Sajjad Ahmad; Annette Meeson; Simi Ali
Journal:  Stem Cells Transl Med       Date:  2013-07-01       Impact factor: 6.940

Review 3.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

Review 4.  The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.

Authors:  Claudia Fabiani; Jurgen Sota; Gian Marco Tosi; Rossella Franceschini; Bruno Frediani; Mauro Galeazzi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-12-28       Impact factor: 2.980

5.  Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury.

Authors:  Steven E Wilson
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.